检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:卢东[1] 蒋小雷[1] 袁强[1] 吴明辉[1] 吴运军[1]
机构地区:[1]川北医学院附属第二医院泌尿外科,四川绵阳621000
出 处:《医药论坛杂志》2012年第11期8-9,12,共3页Journal of Medical Forum
摘 要:目的探讨微创经皮肾镜碎石取石术(MPCNL)治疗开放手术后肾结石的疗效和安全性。方法用微创经皮肾镜碎石取石术治疗23例肾结石患者行开放手术后的残留结石及复发结石,观察结石的取净率、手术时间、术中术后出血量及并发症等情况。结果 23例患者均成功穿刺建立经皮肾碎石取石通道,单通道取石16例,双通道取石6例,三通道取石1例。手术平均时间106min。平均术中出血170ml。2例术中出血至视野不清给予放置肾造瘘管,7d后行二期经皮肾镜手术。术后2例出现延迟性出血。术后4例出现发热,一期手术结石取净率73.9%(17/23)。2例行二期手术,结石总取净率82.6%(19/23)。平均住院时间8.65d,所有患者均无严重并发症发生。结论 MPCNL是治疗肾结石行开放手术后残留结石及复发结石的有安全的手术方法。Objective To explore the efficiency and safety of minimally invasive percutaneous nephrolithotomy(MPCNL) for renal calculi patients with open surgery history stone. Methods Twenty - three patients with residual or recurrent re-nal stones after open surgery were treated by MPCNL. The stone clearance rate, operative time, intraoperative blood loss and complications were observed. Results All cases were treated successfully in one - session procedure, and 16 MPC-NL of these cases were accomplished by single channel,6 cases by double channels and 1 case by three channels. The average operation time was 106 minutes. The average intraoperative blood loss was 172ml. Two patients were given placed renal fistula because of bleeding ledding to the visual field and were treated by second stage MPCNL after 7 days. The postoperative complications were 2 cases of delayed hemorrhage and 4 cases of postoperative fever. The stone clearance rate were 73.9% ( 17/23 ) by one - stage MPCNL,and 2 cases had a second - stage MPCNL and the clearance reached 82. 6% ( 19/23 ). The average hospitalization time is 8.65d, there were no serious complications occurred. Conclusion-s MPCNL is an effective and safety surgical method for renal calculi patients with open surgery history stone.
关 键 词:微创经皮肾镜碎石取石术 肾结石 开发手术
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.173